Clinical Trials for NEC Bio

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: NEC Bio

Clinical Trials (2)

NCT06631092
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer
PHASE1/PHASE2Recruiting
8 participants
Started: Nov 20, 2024 · Completed: Dec 31, 2028
1 condition2 sponsors2 locations
NCT06631079
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors
PHASE1/PHASE2Recruiting
20 participants
Started: Oct 7, 2024 · Completed: Dec 31, 2028
1 condition2 sponsors8 locations